Progenity is a California-based biotechnology company that develops and commercializes therapeutics for the treatment of gastrointestinal diseases.
Read moreFounded
2010
Headquarters
Status
PublicAcquisition Pending from Enumera MolecularNASDAQPROG
SIC Code
Website
Annual Revenue
$ < 1M
Progenity's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 226.3M. Over the last three quarters, Progenity's revenue has decreased by 76.9%. Specifically, in Q1 2022's revenue was $ < 1M; in Q3 2021, it was $ < 1M; in Q2 2021, it was $ < 1M.